FDA Brief

Company record

Apothecary Pharma, LLC

1 FDA warning letter since 2023 and 2 recalls in the last 12 months.

Get an email the day FDA posts anything new about Apothecary Pharma, LLC.

Warning letters

  1. Apothecary Pharma, LLC

    FDA warns Apothecary Pharma, an outsourcing facility, that its sterile compounded drugs were made under insanitary conditions.

    High risk

Recalls

ReportedClassFirmProduct and reason
Oct 14 Class II Apothecary Pharma LLC
Drug
Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC 27513, NDC 85091-001-18.
Lack of Assurance of Sterility
Oct 14 Class II Apothecary Pharma LLC
Drug
Apothecary NAD+ Injection 200 mg/mL, 6 mL Sterile Multi-Dose Vial, Rx Only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC, 27513, NDC 85091-011-06.
Lack of Assurance of Sterility